Saspinjira Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Months 17 Days
About Saspinjira Pharmaceuticals
Saspinjira Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 2024 ( eight months 17 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Bisati, Channabasava Hiremath, Anila Bhandary, and One other member serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U46497KA2024PTC188539
- Company No.
188539
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Who are the key members and board of directors at Saspinjira Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Bisati  | Director | 15-May-2024 | Current |
| Channabasava Hiremath | Director | 15-May-2024 | Current |
| Anila Bhandary | Director | 15-May-2024 | Current |
| Deviprasad Shetty | Director | 15-May-2024 | Current |
Financial Performance of Saspinjira Pharmaceuticals.
Enhance accessibility to Saspinjira Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Saspinjira Pharmaceuticals?
Unlock access to Saspinjira Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Samskruthy Pharma Private LimitedRajeev Bisati and Channabasava Hiremath are mutual person
- Ailabruda Ventures Private Limited
Channabasava Hiremath is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saspinjira Pharmaceuticals?
Unlock and access historical data on people associated with Saspinjira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saspinjira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saspinjira Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.